NCT05766592

Brief Summary

The purpose of this study is to assess the efficacy of an LGBTQ-affirmative individual cognitive behavioral psychotherapy (CBT) and LGBTQ-affirmative family therapy (attachment-based family therapy for sexual and gender minority young adults; ABFT-SGM) delivered via telehealth to a sample of sexual and gender minority adults with nonaccepting parent(s) in New York, Pennsylvania, Connecticut, and Israel. The investigators will assess whether both treatments are associated with significant decreases in depressive and anxiety symptoms. The investigators will also assess whether and how each treatment achieves reductions in mental health symptoms through specific mechanisms (e.g., rejection sensitivity, internalized stigma, emotion dysregulation, parental rejection and acceptance).

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P25-P50 for phase_3

Timeline
14mo left

Started Aug 2024

Typical duration for phase_3

Geographic Reach
2 countries

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Aug 2024Jun 2027

First Submitted

Initial submission to the registry

March 1, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 13, 2023

Completed
1.4 years until next milestone

Study Start

First participant enrolled

August 13, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

January 13, 2026

Status Verified

January 1, 2026

Enrollment Period

2.9 years

First QC Date

March 1, 2023

Last Update Submit

January 12, 2026

Conditions

Keywords

LGBTQCognitive Behavioral TherapyAttachment-Based Family Therapy

Outcome Measures

Primary Outcomes (2)

  • Change in depression symptoms

    Depressive symptoms will be measured using the 21-item Beck Depression Inventory-II (BDI). Items are rated on a scale from 0-3 where higher scores indicate greater depression symptoms, with a maximum score of 63.

    Baseline, Immediate Post-intervention, 5-month Post-intervention

  • Change in anxiety symptoms

    Anxiety symptoms will be measured using the 21-item Beck Anxiety Inventory (BAI). Items are rated on a scale from 0-3 where higher scores indicate greater anxiety symptoms, with a maximum score of 63.

    Baseline, Immediate Post-intervention, 5-month Post-intervention

Secondary Outcomes (9)

  • Change in suicidal ideation

    Baseline, Immediate Post-intervention, 5-month Post-intervention

  • Change in sexual orientation and gender modality concealment motivation, as relevant

    Baseline, Immediate Post-intervention, 5-month Post-intervention

  • Change in sexual orientation and gender modality acceptance concerns, as relevant

    Baseline, Immediate Post-intervention, 5-month Post-intervention

  • Change in explicit internalized stigma

    Baseline, Immediate Post-intervention, 5-month Post-intervention

  • Change in emotion dysregulation

    Baseline, Immediate Post-intervention, 5-month Post-intervention

  • +4 more secondary outcomes

Study Arms (2)

LGBTQ-affirmative CBT

EXPERIMENTAL

Individuals assigned to LGBTQ-affirmative cognitive behavioral therapy will receive 16 weekly individually-delivered sessions, directly after baseline assessment, delivered via telehealth. Based on the Unified Protocol, sessions will address minority stress mechanisms underlying sexual and gender minority mental health disparities.

Behavioral: LGBTQ-affirmative CBT

ABFT-SGM

EXPERIMENTAL

Individuals assigned to attachment-based family therapy for sexual and gender minorities will receive a 16-session sequence of family-based therapy delivered via telehealth. This sequence will include sessions with sexual and/or gender minority adult children alone, adult children and parent(s), and parent(s) alone. Sessions will address the quality parent-child relationship in relation to child sexual orientation and gender identity to target mental health disparities.

Behavioral: ABFT-SGM

Interventions

ABFT-SGMBEHAVIORAL

16-session attachment-based family therapy for sexual and gender minority young adults and their nonaccepting parents

ABFT-SGM

16-session LGBTQ-affirmative psychotherapy using cognitive behavioral techniques

LGBTQ-affirmative CBT

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be 20 and older
  • be fluent in English
  • self-identify as lesbian, bisexual, queer, pansexual, or other non-heterosexual identity
  • currently experience elevated depressive or anxiety symptoms (screened initially using a cutoff of ≥ 2.5 on the Brief Symptom Inventory-4 and further confirmed by the BDI and BAI).
  • report at least moderate levels of parental rejection or low levels of parental acceptance, as measured using the PARSOS.
  • have at least one rejecting/nonaccepting parent that agrees to participate in the therapy.
  • live in New York State, Pennsylvania, Connecticut, or Israel.

You may not qualify if:

  • report current mental health treatment ≥1 day/month (except for medication management ≤1 day/week)
  • report beginning a new medication within the past 30 days
  • exhibit active psychosis or active mania, as assessed by the SCID-Psych Screen.
  • exhibit active suicidality or active homicidality, as assessed by the SIDAS
  • be currently legally mandated to attend treatment
  • demonstrate gross cognitive impairment, as assessed with the Telephone Interview for Cognitive Status
  • do not have a parent willing to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Yale LGBTQ Mental Health Initiative with the Yale School of Public Health Office

New York, New York, 10001, United States

NOT YET RECRUITING

Ben-Gurion University Psychotherapy Research Lab

Beersheba, 84105, Israel

RECRUITING

Related Publications (12)

  • Wang YP, Gorenstein C. Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Braz J Psychiatry. 2013 Oct-Dec;35(4):416-31. doi: 10.1590/1516-4446-2012-1048. Epub 2013 Dec 23.

    PMID: 24402217BACKGROUND
  • Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available.

    PMID: 3204199BACKGROUND
  • Mohr JJ, Kendra MS. Revision and extension of a multidimensional measure of sexual minority identity: the Lesbian, Gay, and Bisexual Identity Scale. J Couns Psychol. 2011 Apr;58(2):234-245. doi: 10.1037/a0022858.

    PMID: 21319899BACKGROUND
  • Gouveia P, Ramos C, Brito J, Almeida TC, Cardoso J. The Difficulties in Emotion Regulation Scale - Short Form (DERS-SF): psychometric properties and invariance between genders. Psicol Reflex Crit. 2022 May 6;35(1):11. doi: 10.1186/s41155-022-00214-2.

    PMID: 35522349BACKGROUND
  • Kibrik EL, Cohen N, Stolowicz-Melman D, Levy A, Boruchovitz-Zamir R, Diamond GM. Measuring Adult Children's Perceptions of Their Parents' Acceptance and Rejection of Their Sexual Orientation: Initial Development of the Parental Acceptance and Rejection of Sexual Orientation Scale (PARSOS). J Homosex. 2019;66(11):1513-1534. doi: 10.1080/00918369.2018.1503460. Epub 2018 Aug 24.

    PMID: 30142289BACKGROUND
  • Kasch KL, Klein DN, Lara ME. A construct validation study of the Response Styles Questionnaire Rumination Scale in participants with a recent-onset major depressive episode. Psychol Assess. 2001 Sep;13(3):375-83. doi: 10.1037//1040-3590.13.3.375.

    PMID: 11556274BACKGROUND
  • Steffens MC, Buchner A. Implicit Association Test: separating transsituationally stable and variable components of attitudes toward gay men. Exp Psychol. 2003;50(1):33-48. doi: 10.1027//1618-3169.50.1.33.

    PMID: 12629959BACKGROUND
  • Fraley RC, Heffernan ME, Vicary AM, Brumbaugh CC. The Experiences in Close Relationships-Relationship Structures questionnaire: a method for assessing attachment orientations across relationships. Psychol Assess. 2011 Sep;23(3):615-25. doi: 10.1037/a0022898.

    PMID: 21443364BACKGROUND
  • Tolin DF, Gilliam C, Wootton BM, Bowe W, Bragdon LB, Davis E, Hannan SE, Steinman SA, Worden B, Hallion LS. Psychometric Properties of a Structured Diagnostic Interview for DSM-5 Anxiety, Mood, and Obsessive-Compulsive and Related Disorders. Assessment. 2018 Jan;25(1):3-13. doi: 10.1177/1073191116638410. Epub 2016 Mar 17.

    PMID: 26988404BACKGROUND
  • Lang AJ, Norman SB, Means-Christensen A, Stein MB. Abbreviated brief symptom inventory for use as an anxiety and depression screening instrument in primary care. Depress Anxiety. 2009;26(6):537-43. doi: 10.1002/da.20471.

    PMID: 19016462BACKGROUND
  • Cook SE, Marsiske M, McCoy KJ. The use of the Modified Telephone Interview for Cognitive Status (TICS-M) in the detection of amnestic mild cognitive impairment. J Geriatr Psychiatry Neurol. 2009 Jun;22(2):103-9. doi: 10.1177/0891988708328214.

    PMID: 19417219BACKGROUND
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

    PMID: 11556941BACKGROUND

Study Officials

  • John E Pachankis, PhD

    Yale University

    PRINCIPAL INVESTIGATOR
  • Gary M Diamond, PhD

    Ben-Gurion University of the Negev

    PRINCIPAL INVESTIGATOR

Central Study Contacts

John E Pachankis, PhD

CONTACT

Danielle M Chiaramonte, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will be immediately assigned to either condition.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2023

First Posted

March 13, 2023

Study Start

August 13, 2024

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

January 13, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

De-identified individual participant data will be made available to qualified researchers upon request to the PIs following study conclusion.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Data will be available 12 months after study completion for three years.
Access Criteria
Data access requests from qualified academic investigators for non-commercial research interests will be reviewed by study investigators. Requestors will be required to sign a data access agreement.

Locations